These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4940644)

  • 21. Pathogenesis of pulmonary Mycobacterium bovis infection: basic principles established by the rabbit model.
    Dannenberg AM
    Tuberculosis (Edinb); 2001; 81(1-2):87-96. PubMed ID: 11463228
    [No Abstract]   [Full Text] [Related]  

  • 22. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quarter of a century in the field of BCG.
    Rodopska S
    Dev Biol Stand; 1986; 58 ( Pt A)():257-72. PubMed ID: 3297865
    [No Abstract]   [Full Text] [Related]  

  • 24. [Consideration on the evaluation of the immunizing power of BCG].
    Panisset M
    Bull Int Union Tuberc; 1968 Dec; 41():31-5. PubMed ID: 4885382
    [No Abstract]   [Full Text] [Related]  

  • 25. Rapid identification of Mycobacterium bovis BCG by the detection of the RD1 deletion using a multiplex PCR technique.
    Kearns AM; Magee JG; Gennery A; Steward M; Graham C; Seiders PR; Freeman R
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):635-8. PubMed ID: 10423228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The level and spectrum of antituberculosis antibodies in BCG-vaccinated mice and in mice and rabbits infected with a virulent mycobacterial culture].
    Markov AN; Nikonenko BV; Chernousova LN; Levi DT; Dem'ianenko NV; Litvinov VI
    Probl Tuberk; 1993; (1):43-4. PubMed ID: 8327439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of 3 daughter strains of BCG (French, Danish and Rumanian)].
    Miron S; Sturdza SA; Petrovici M; Rîmniceanu I
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):595-9. PubMed ID: 4939331
    [No Abstract]   [Full Text] [Related]  

  • 30. Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety.
    Chen JM; Islam ST; Ren H; Liu J
    Vaccine; 2007 Nov; 25(48):8114-22. PubMed ID: 17954004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential correlates of BCG induced protection against tuberculosis detected in a mouse aerosol model using gene expression profiling.
    Rodgers A; Whitmore KM; Walker KB
    Tuberculosis (Edinb); 2006; 86(3-4):255-62. PubMed ID: 16600686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83.
    Chambers MA; Vordermeier H; Whelan A; Commander N; Tascon R; Lowrie D; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S283-7. PubMed ID: 10875801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of the inoculation route on residual virulence of different substrains of BCG for albino mice].
    Palhano Junior L; Gontijo Filho PP
    Rev Inst Med Trop Sao Paulo; 1980; 22(1):15-9. PubMed ID: 7001603
    [No Abstract]   [Full Text] [Related]  

  • 34. [Characteristics of acid-fast organisms isolated from tuberculous lymphadenitis-lesion of two children who had been BCG-vaccinated. Differentiation of BCG from other strains of Mycobacterium bovis].
    Tsukamura M; Shoji R; Matsuda K
    Kekkaku; 1984 Apr; 59(4):289-93. PubMed ID: 6379259
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of BCG vaccine on the growth of Krebs-2 tumor].
    Kaledin VI; Kovalevskiĭ GV; Kurunov IuN; Matienko NA
    Vopr Onkol; 1974 Oct; 20(7):70-5. PubMed ID: 4605643
    [No Abstract]   [Full Text] [Related]  

  • 37. [SURVIVAL AND MULTIPLICATION OF BCG AND OF THE TUBERCLE BACILLUS IN MICE. IV. SURVIVAL AND MULTIPLICATION OF BCG DAUGHTER STRAINS AS A FUNCTION OF TIME AND DOSAGE].
    BENOIT JC; PANISSET M
    Acta Tuberc Pneumol Scand; 1963; 43():125-36. PubMed ID: 14061579
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tuberculosis vaccination--knowledge, experience and perspectives].
    Ganguin HG; Mydlak G; Zureck A
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 130(1):101-39. PubMed ID: 4899216
    [No Abstract]   [Full Text] [Related]  

  • 39. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.